Vassiliki A. Boussiotis

Vassiliki A. Boussiotis

Division of Hematology-Oncology, Harvard Medical School

Affiliated withHarvard Medical SchoolBeth Israel Deaconess Medical Center, Harvard Medical School

Research Area

Biography

Vassiliki A. Boussiotis has not added Biography.
If you are Vassiliki A. Boussiotis and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
Unraveling Key Players of Humoral Immunity: Advanced and Optimized Lymphocyte Isolation Protocol from Murine Peyer's Patches
Publication title

Cited by 3

2018
2021

Other Publications

Article
Year
CTLA-4 regulates cell cycle progression during a primary immune response.

European journal of immunology| PubMed ID: 11807776

2002
2002
2002
Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 12032325

2002
2004
2004
2004
2004
2005
2005
Rap1 regulation of RIAM and cell adhesion.

Methods in enzymology| PubMed ID: 16757337

2006
2006
2006
2006
2007
2008
CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 18410894

2008
2009
2008
The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19073936

2008
2009
2009
2009
2010
2010
2011
Molecular and functional heterogeneity of T regulatory cells.

Clinical immunology (Orlando, Fla.)| PubMed ID: 21945485

2011
2012
2012
2012
2012
RIAM (Rap1-interacting adaptor molecule) regulates complement-dependent phagocytosis.

Cellular and molecular life sciences : CMLS| PubMed ID: 23420480

2013
2013
2013
2014
Biochemical signaling of PD-1 on T cells and its functional implications.

Cancer journal (Sudbury, Mass.)| PubMed ID: 25098287

2014
2014
Somatic mutations and immunotherapy outcome with CTLA-4 blockade in melanoma.

The New England journal of medicine| PubMed ID: 25409261

2014
2015
2015
Regulation of T Cell Differentiation and Function by EZH2.

Frontiers in immunology| PubMed ID: 27199994

2016
Clinical significance of T cell metabolic reprogramming in cancer.

Clinical and translational medicine| PubMed ID: 27510264

2016
2016
Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 27777141

2017
2016
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.

Frontiers in immunology| PubMed ID: 28018338

2016
The role of metabolic reprogramming in T cell fate and function.

Current trends in immunology| PubMed ID: 28356677

2016
2017
2017
2017
2016
Feeling stressed? It might be your T cells.

Nature immunology| PubMed ID: 29144505

2017
Immunotherapies for malignant glioma.

Oncogene| PubMed ID: 29242608

2018
2018
2018
2018